Michele Park

Michele Park

Partner atNew Enterprise Associates (NEA)Firm active Oct 6US

Michele Park is a Venture Partner at NEA focusing on biopharma. She joined in 2021 and previously worked at Clarus Ventures, Credit Suisse, and Piper Jaffray.

What Michele can write

Writes checks of$1M to $30M+
Comes in atPre-seed, Seed, Series A, Series BCan lead the round
Ownership target7-10%At first check
Best routeA warm introAsk a founder in their portfolio.

New Enterprise Associates (NEA) writes $1M to $30M+ checks, larger than 83% of firms in the atlas.

Bars: how many firms report each check band. Highlighted: New Enterprise Associates (NEA).

Career

  1. Piper Jaffray · biotechnology research analyst
  2. Credit Suisse · biotechnology research analyst
  3. Clarus Ventures (now Blackstone Life Sciences) · investor
  4. Credit Suisse · research analyst
  5. Piper Jaffray · research analyst
  6. Clarus Ventures · Partner
  7. New Enterprise Associates · Venture Partner
    Now

Investments named in public bios

AbcuroChromaCodeTiger Aesthetics Medical, LLC

Focus

healthcarebiopharmaseed/earlygrowthLife SciencesDigital Health

Education

Weill Cornell Graduate School of Medical Sciences, PhD in molecular biologyPrinceton, BA in molecular biology

Also at New Enterprise Associates (NEA)

Partners like Michele

At firms with a similar stage, sector and check size.

Alert me when New Enterprise Associates (NEA) is active

One email when Michele's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Michele Park?

Michele Park is a Venture Partner at NEA focusing on biopharma. She joined in 2021 and previously worked at Clarus Ventures, Credit Suisse, and Piper Jaffray.

How much does Michele Park invest?

Michele Park invests through New Enterprise Associates (NEA), which writes checks of $1M to $30M+ at pre-seed, seed, series a, series b.

How do I pitch Michele Park?

A warm intro from a founder New Enterprise Associates (NEA) backed works best.

What did Michele Park do before New Enterprise Associates (NEA)?

biotechnology research analyst at Piper Jaffray; biotechnology research analyst at Credit Suisse; investor at Clarus Ventures (now Blackstone Life Sciences); research analyst at Credit Suisse; research analyst at Piper Jaffray; Partner at Clarus Ventures.

Last updated 2026-10-15. Is this you? Ask for a correction.